Rite Aid closures adding up. Is your favorite Tacoma-area store on the list?
A court filing entered May 23 included the following locations in the state among 151 additional stores set to close nationwide:
▪ Auburn: 1509 Auburn Way S.
▪ Maple Valley: 22117 SE 237th St. (Bartell Drugs)
▪ Milton: 900 East Meridian Suite 23
▪ Port Orchard: 3282 Bethel Road S.E.
▪ University Place: 3840 Bridgeport Way W.
Thirteen sites in the state, mostly Rite Aid but a few involving its subsidiary Bartell Drug, have been slated as closing, including previously announced locations in Anacortes, Ephrata, Granite Falls, Kingston, North Bend, Omak, Snoqualmie and Yelm.
No specific closure dates were included, and Rite Aid representatives as of Wednesday afternoon had not responded to The News Tribune's request for more information.
The Idaho Statesman reported this week that two Idaho stores added to the latest list are slated to close in June, with the retail and pharmacies closing on different dates.
A Worker Adjustment and Training Notification filing with the state of Washington on May 7 listed 131 layoffs with Bartell Drug (Rite Aid) Distribution Center in Des Moines starting June 4.
Both Bartell and Rite Aid have imposed deadlines for returns and gift card use as of June 5, and Rite Aid Rewards points stopped being issued on May 6.
Rite Aid in mid-May announced that it had entered into a series of 'sale agreements and pharmacy services transition agreements' involving more than 1,000 stores.
In Washington state, it noted the 'the sale and operation by CVS Pharmacy of many Rite Aid and Bartell Drugs stores located in Washington, Oregon and Idaho.'
Amy Thibault is executive director, corporate communications – external Affairs for CVS Health. In an emailed statement, she told The News Tribune earlier this month, 'CVS Pharmacy participated in a bankruptcy court approved bidding process and has agreed to acquire the prescription files of 625 Rite Aid pharmacies across fifteen states in areas that CVS serves and to acquire and operate 64 Rite Aid stores in Idaho, Oregon, and Washington.'
CVS's bids were approved May 21 by the The U.S. Bankruptcy Court of New Jersey, and a release from CVS stated, 'Additional details will be available closer to the transaction closing dates in the coming weeks.'
Sites that remain on Rite Aid's website as open in Pierce County include two stores in Tacoma (1912 N. Pearl St. and 7041 Pacific Ave.) stores in Bonney Lake, Lakewood and Spanaway and four locations in Puyallup. Bartell has three sites remaining in Pierce County (two in Tacoma, one in Gig Harbor).
As for the switch, Thibault said CVS was working to ensure a 'seamless' transition for patients and customers with no interruptions of pharmacy care.
'Once the sale is finalized, we look forward to welcoming Rite Aid colleagues who are interested in applying to join the CVS team.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
Eli Lilly and Co (LLY) Traded Lower in Q2 Despite Good Results
Impax Asset Management, an investment management company, released its 'Impax US Sustainable Economy Fund' second quarter 2025 investor letter. A copy of the letter can be downloaded here. In 2025's second quarter, tariffs triggered market declines and recession fears, but a pause in tariffs sparked a historic rally as earnings remained resilient. In the second quarter of 2025, the fund underperformed the Russell 1000 benchmark. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its second-quarter 2025 investor letter, Impax US Sustainable Economy Fund highlighted stocks such as Eli Lilly and Company (NYSE:LLY). Eli Lilly and Company (NYSE:LLY) is a pharmaceutical company headquartered in Indianapolis, Indiana. The one-month return of Eli Lilly and Company (NYSE:LLY) was -2.66%, and its shares lost 0.80% of their value over the last 52 weeks. On August 5, 2025, Eli Lilly and Company (NYSE:LLY) stock closed at $765.95 per share, with a market capitalization of $687.621 billion. Impax US Sustainable Economy Fund stated the following regarding Eli Lilly and Company (NYSE:LLY) in its second quarter 2025 investor letter: "Eli Lilly and Company (NYSE:LLY) (Health Care, Pharmaceuticals) boasts an innovative drug portfolio that has the potential to transform the standard of care across several diseases. The stock was weaker in the quarter despite results that were in-line or better than expectations. Shares were under pressure after CVS' announcement that competitor Novo Nordisk's Wegovy will now be the preferred GLP-1 drug on their national formulary, which currently represents a mid-single digit percentage of Lilly's current Zepbound patients." li Lilly and Company (NYSE:LLY) is in 21st position on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 119 hedge fund portfolios held Eli Lilly and Company (NYSE:LLY) at the end of the first quarter, which was 115 in the previous quarter. Eli Lilly and Company (NYSE:LLY) reported strong results in first quarter of 2025, with revenue increasing 45% compared to Q1 2024. While we acknowledge the potential of Eli Lilly and Company (NYSE:LLY) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Eli Lilly and Company (NYSE:LLY) and shared the list of most profitable growth stocks to buy according to billionaires. RiverPark Large Growth Fund noted in its Q2 2025 letter that Eli Lilly (NYSE: LLY) experienced a stock decline despite strong revenue growth. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
a day ago
- Yahoo
CVS Lifts 2025 Adjusted EPS Forecast Again: What's Driving the Move?
CVS Health CVS reported its second-quarter 2025 results last week, wherein adjusted operating income (AOI) rose 2% year over year to approximately $3.80 billion. This was supported by 39.4% AOI growth in Health Care Benefits and 7.6% in Pharmacy & Consumer Wellness ('PCW'). Adjusted earnings per share (EPS) came in at $1.81, down two cents from the prior-year quarter. Impressively, CVS raised its full-year earnings guidance to a range of $6.30-$6.40, up from the $6.00-$6.20 outlook shared in February, marking its second upward revision this year. Performance and positive outlooks reflect the benefits of the company's diversified model. Aetna's multi-year margin recovery is a top priority, and CVS is making progress through organizational realignment, enhancing its talent, and using technology to automate and simplify processes. Medicare has been a key driver of this progress — supported by strong STARS for the payment year 2025, rationalization of both geographies and product mix through the Annual Enrollment Period, and CVS' ability to understand cost trends and mitigate them whenever possible. Meanwhile, Caremark maintains a strong position in the pharmacy benefit management market, with retention rates staying around the 90% historical level. CVS continues its efforts to reduce prescription and pharmacy costs by promoting competition, such as leading with Cordavis in the biosimilar space and, most recently, in weight loss indications on GLP-1. In retail pharmacy, the company focuses on ensuring ongoing access to medication across the country. PCW delivered another strong quarter despite ongoing reimbursement pressures, demonstrating the company's ability to adapt to market changes. Meanwhile, Health Care Delivery saw incremental pressure in the second quarter due to higher medical benefit ratios at Oak Street. CVS is working to improve the business through investments in technology, leadership changes and stronger partnerships with payer clients to ensure seniors continue to benefit from the industry-leading model. CVS Health's Rival Performance Amazon AMZN reported worldwide operating income of $19.2 billion in the second quarter of 2025, up 30.6% year over year and $1.7 billion above its guidance range. The North America segment's operating margin rose 190 basis points (bps) year over year, while the International operating margin climbed 320 bps. AWS margins declined to 32.9% from a record high of 39.5% in the first quarter. Amazon saw productivity gains in the transportation network, led by improved inventory placement, strong leverage on high unit volumes, and higher levels of in-demand inventory from both first-party and third-party selling partners. Elevance Health ELV posted an operating gain of $1.6 billion in the Health Benefits segment, which was mainly impacted by higher medical cost trends in its Medicaid business and Affordable Care Act health plans. Meanwhile, Carelon's operating gain totaled $0.9 billion, up 33% year over year, primarily driven by improved Carelon Health performance and higher CarelonRx product revenues. On a consolidated basis, ELV's adjusted operating expense ratio improved 140 bps to 10%, thanks to expense leverage associated with growth in operating revenues and ongoing expense discipline. CVS' Price Performance, Valuation and Estimates In the past six months, CVS Health shares have risen 13.2% against the industry's 10.8% fall. Image Source: Zacks Investment Research CVS shares are trading at a forward 12-month price-to-earnings ratio of 9.14, much discounted from the 13.93 industry average. The stock sits with a Value Score of A. Image Source: Zacks Investment Research In the past seven days, analyst estimates for the company's 2025 and 2026 earnings have increased 1.5% and 1%, respectively. Image Source: Zacks Investment Research CVS stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inc. (AMZN) : Free Stock Analysis Report CVS Health Corporation (CVS) : Free Stock Analysis Report Elevance Health, Inc. (ELV) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
5 days ago
- Yahoo
Senior Discounts and 4 Other Ways Boomers Can Cash in
During working years, it may seem like retirement will be a time of relaxation and reduced spending. But according to Fidelity, most retirees can expect to spend 55 to 80% of their annual income while working each year in retirement. Check Out: Learn More: If you're already retired, or at least reached the age of 50, there are many discounts and other ways to save a good amount of money. Keep in mind you may need to ask for discounts in order to take advantage of them. Restaurant Offerings Perhaps one of the best everyday perks of being a senior is enjoying your favorite restaurant meals for less. Plenty of places offer a senior discount — and some even have special menus for those over a certain age. In fact, if you don't see these things, it may be smart to ask about them. Local eateries that aren't part of national chains may have special senior discounts that aren't widely advertised. For You: Healthcare Options When it comes to discounts and other ways to save money as a senior, perhaps one of the most important is on health care and medications. According to My Care Finders, a lot of pharmacies give seniors discounts on prescriptions and wellness items. Walgreens and CVS are among the places to ask about such discounts. Inexpensive Entertainment Amazon does offer a pretty good discount on Prime membership for those relying on some government assistance programs. In addition, you can check to see if your local theaters have senior discounts or special days with lower prices for those over a certain age. If you're a fan of amusement or theme parks, they generally offer pretty big discounts on tickets for seniors. Further, according to AARP, you may be able to save some serious money with discount rates from major cruise lines. Also, look for discounts on Greyhound bus travel and through some airlines. Cheaper Clothing Check out the senior discounts and days available at some popular clothing stores. Your local Kohls, Ross and Goodwill stores are among the places to look for cheaper clothing. Discount days may also be good opportunities for socializing with other seniors. More From GOBankingRates 6 Big Shakeups Coming to Social Security in 2025 This article originally appeared on Senior Discounts and 4 Other Ways Boomers Can Cash in
